KASINGER JAMES R.
SEC insider (Form 3/4/5 filer). CIK 0001708172. General Counsel and Secretary at CRISPR Therapeutics AG (CRSP). 36 reported Form 4/5 transactions since Sep 2024; latest on Oct 14, 2026. Located in BOSTON, MA.
Companies KASINGER JAMES R. has filed insider reports for
- CRISPR Therapeutics AG (CRSP): Officer, General Counsel and Secretary
KASINGER JAMES R.
CIK: 0001708172
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CRISPR Therapeutics AG
Discretionary Trading P&L
Holdings
Transaction History (36 total)
- Oct 14, 2026CRSP
CRISPR Therapeutics AG
SaleDirect1K shares at avg. $49.26$51K - Oct 13, 2026CRSP
CRISPR Therapeutics AG
ExerciseDirect2.1K shares- - Oct 6, 2026CRSP
CRISPR Therapeutics AG
ExerciseDirect2K shares at avg. $13.62$27K - Oct 6, 2026CRSP
CRISPR Therapeutics AG
SaleDirect2K shares at avg. $60.04$119K - Sep 22, 2026CRSP
CRISPR Therapeutics AG
SaleDirect10.4K shares at avg. $60.24$626K - Sep 22, 2026CRSP
CRISPR Therapeutics AG
ExerciseDirect10.4K shares at avg. $13.62$142K - May 29, 2026CRSP
CRISPR Therapeutics AG
AwardDirectRestricted Stock Units
17K shares- - Mar 23, 2026CRSP
CRISPR Therapeutics AG
SaleDirect3.2K shares at avg. $46.78$149K - Mar 20, 2026CRSP
CRISPR Therapeutics AG
ExerciseDirect6.3K shares- - Mar 20, 2026CRSP
CRISPR Therapeutics AG
AwardDirectStock Option (Right to Buy)
38.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 14, 2026 | CRSP CRISPR Therapeutics AG | Sale | 1,040 | $49.26 | $51,230 | Direct |
| Oct 13, 2026 | CRSP CRISPR Therapeutics AG | Exercise | 2,113 | - | $0 | Direct |
| Oct 6, 2026 | CRSP CRISPR Therapeutics AG | Exercise | 1,990 | $13.62 | $27,104 | Direct |
| Oct 6, 2026 | CRSP CRISPR Therapeutics AG | Sale | 1,990 | $60.04 | $119,481 | Direct |
| Sep 22, 2026 | CRSP CRISPR Therapeutics AG | Sale | 10,400 | $60.24 | $626,460 | Direct |
| Sep 22, 2026 | CRSP CRISPR Therapeutics AG | Exercise | 10,400 | $13.62 | $141,648 | Direct |
| May 29, 2026 | CRSP CRISPR Therapeutics AG | Award Restricted Stock Units | 17,000 | - | - | Direct |
| Mar 23, 2026 | CRSP CRISPR Therapeutics AG | Sale | 3,182 | $46.78 | $148,854 | Direct |
| Mar 20, 2026 | CRSP CRISPR Therapeutics AG | Exercise | 6,250 | - | $0 | Direct |
| Mar 20, 2026 | CRSP CRISPR Therapeutics AG | Award Stock Option (Right to Buy) | 38,499 | - | - | Direct |
1-10 of 36 transactions